Nav: Home

Breast cancer 'ecosystem' reveals possible new targets for treatment

August 13, 2020

Researchers from the Garvan Institute of Medical Research have uncovered four new subtypes of cells within triple negative breast cancer, which contain promising new therapeutic targets for the aggressive disease.

Using cellular genomics, the team revealed one of the new cell types produces molecules that suppress immune cells, which may help cancer cells evade the body's immune system. The discovery, published in EMBO Journal, could lead to a new class of therapies for triple negative breast cancer.

"Patients with triple negative breast cancers have a poor prognosis, in large part because treatment approaches have advanced very slowly," says senior author Associate Professor Alex Swarbrick, Head of the Tumour Progression Laboratory at Garvan. "We've analysed individual cells in patient tumour samples to gain unprecedented insights into what makes up a tumour, allowing us to identify subtypes of cells and investigate their role in disease."

Triple negative breast cancer: new targets for therapy

By definition, triple negative breast cancers lack three receptors (for oestrogen, progesterone and the HER2 protein) that are targeted with specialised therapies in other breast cancers. This leaves patients with limited treatment options and poor outcomes - a substantial proportion of patients diagnosed with the cancer die within five years of diagnosis.

"In our study, we searched for new potential targets for therapy by analysing the individual cells inside triple negative breast tumours. This includes not only the cancer cells themselves, but also the surrounding host cells, such as immune and connective tissue cells, which can be thought of as the cancer 'ecosystem' that supports a tumour to grow and spread," explains Sunny Wu, first author of the study.

The researchers used next-generation sequencing of 24,271 individual cells extracted from biopsy samples of five triple negative breast cancer patients, and detected over 6000 unique RNA molecules in every cell, creating a snapshot of each cell's gene activity.

By analysing the profiles of active genes, the researchers revealed four cell subtypes of stromal cells, which form the connective tissues in the body. Previous studies in triple negative breast cancers had generally considered there to be only one type of stromal cell.

Cancer's 'ecosystem' suppresses the immune system


The researchers investigated further to understand what role these four cell subtypes might play in triple negative breast cancers. They revealed surprising interactions between the signalling molecules produced by the stromal cells and immune cells.

"Our findings suggest that there is significant crosstalk between the immune system and stromal cells, which were generally thought to have only a structural role in cancers," says Associate Professor Swarbrick.

For instance, the team found that one of the cell subtypes they discovered in the breast cancers, so-called inflammatory cancer-associated fibroblasts or 'iCAFs', released the chemokine CXCL12, a signalling molecule known to suppress the anti-tumour activity of T cells.

"This is significant because immunotherapy - which is designed to activate the patient's immune system against a tumour - has limited response in many patients with triple negative breast cancer," Associate Professor Swarbrick adds. "If iCAFs are suppressing T cells in triple negative breast cancer, and we can remove this interaction, T cells will be more susceptible to activation and more likely to attack the cancer."

New directions for cancer treatment


The researchers say that combining immunotherapy with a treatment that stops the interaction between stromal cells and immune cells holds promise for improving the treatment of triple negative breast cancer.

The team will now analyse further breast cancer samples, to obtain an even better understanding of the cells that comprise triple negative breast cancers, their interactions and how these can be intervened with to stop disease progression.

"Pathologists have been describing cancers under the microscope for more than 150 years, but we still only have a shallow understanding of the cells that are there," says Associate Professor Swarbrick. "Cellular genomics is showing us that what we once thought of as one cell type is in reality a diversity of cell types, which will have a significant impact on how we tailor treatments in future."

The data generated in this study forms part of the Breast Cancer Cell Atlas, an ambitious initiative to sequence more than a million individual cells from patient breast tumours to create the most comprehensive view of breast cancer cells yet, undertaken in collaboration with the Garvan-Weizmann Centre for Cellular Genomics.
-end-
This research was supported by funding from the National Breast Cancer Foundation (NBCF) of Australia, Mr John McMurtrie AM and Mrs Deborah McMurtrie, G P Harris Foundation, Skipper-Jacobs Charitable Trust and the Sydney Breast Cancer Foundation.

A/Prof Swarbrick is the Petre Foundation Chair for Breast Cancer Research and Senior Research Fellow of the NHMRC.

Garvan Institute of Medical Research

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.